Bisphosphonates and osteonecrosis of the jaw

Med J Aust. 2005 Apr 18;182(8):417-8. doi: 10.5694/j.1326-5377.2005.tb06762.x.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Administration, Oral
  • Adult
  • Adverse Drug Reaction Reporting Systems*
  • Aged
  • Aged, 80 and over
  • Australian Capital Territory
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / secondary*
  • Diphosphonates / administration & dosage
  • Diphosphonates / adverse effects*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Injections, Intravenous
  • Long-Term Care
  • Male
  • Mandibular Diseases / chemically induced*
  • Mandibular Diseases / diagnosis
  • Mandibular Diseases / pathology
  • Maxillary Diseases / chemically induced*
  • Maxillary Diseases / diagnosis
  • Maxillary Diseases / pathology
  • Middle Aged
  • Osteonecrosis / chemically induced*
  • Osteonecrosis / diagnosis
  • Osteonecrosis / pathology

Substances

  • Diphosphonates